Literature DB >> 9466313

Evidence for CD4+ T cell responses common to Plasmodium falciparum and recall antigens.

M R Goodier1, G A Targett.   

Abstract

In individual donors which have never been exposed to malaria parasites, the CD4+ T cell precursor frequencies for tetanus toxoid (TT) and Plasmodium falciparum responses are similar (range 1:850-1:4800). Limiting dilution cultures set up in response to P. falciparum trophozoites can be re-stimulated with the same stage of the parasite or TT and respond with similar frequencies. A substantial overlap in the responses to different agents was confirmed in suicide selection experiments where cells responding to malaria parasite, TT or influenza virus antigens were deleted using the cell cycle inhibitor cytosine arabinoside (Ara-C). The responses of the remaining cells to P. falciparum were almost completely abrogated and only weak responses were observed to different recall antigens (0.2-21% of untreated control). Little or no effect was observed on the responses to superantigen or mitogen. Furthermore, in contrast to superantigen, the observed responses to TT and Plasmodium were polyclonal, the blastoid cells generated reacting with a range of anti-TCR Vbeta antibodies with little preferential usage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9466313     DOI: 10.1093/intimm/9.12.1857

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  Modulation of the immune and inflammatory responses by Plasmodium falciparum schizont extracts: role of myeloid dendritic cells in effector and regulatory functions of CD4+ lymphocytes.

Authors:  Ann Maria Clemente; Giulia Fadigati; Roberto Caporale; Damiano G Marchese; Giuseppe Castronovo; Anna Rosa Sannella; Carlo Severini; Federica Verra; Enrico Garaci; Federico Cozzolino; Maria Gabriella Torcia
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

Review 2.  Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings.

Authors:  Charles Mulamba; Chris Williams; Katharina Kreppel; Jean Bosco Ouedraogo; Ally I Olotu
Journal:  Malar J       Date:  2022-06-02       Impact factor: 3.469

3.  Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity.

Authors:  Jiraprapa Wipasa; Lucy Okell; Supachai Sakkhachornphop; Chaisuree Suphavilai; Kriangkrai Chawansuntati; Witaya Liewsaree; Julius C R Hafalla; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

4.  A whole parasite transmission-blocking vaccine for malaria: an ignored strategy.

Authors:  Michael F Good; Stephanie K Yanow
Journal:  Emerg Top Life Sci       Date:  2017-12-22

Review 5.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

Review 6.  The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development.

Authors:  Wilson L Mandala; Visopo Harawa; Fraction Dzinjalamala; Dumizulu Tembo
Journal:  Mol Biochem Parasitol       Date:  2021-10-16       Impact factor: 1.759

7.  Mast Cell Chymase/Mcpt4 Suppresses the Host Immune Response to Plasmodium yoelii, Limits Malaria-Associated Disruption of Intestinal Barrier Integrity and Reduces Parasite Transmission to Anopheles stephensi.

Authors:  Nora Céspedes; Erinn L Donnelly; Casey Lowder; Gretchen Hansten; Delaney Wagers; Anna M Briggs; Joseph Schauer; Lori Haapanen; Magnus Åbrink; Judy Van de Water; Shirley Luckhart
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.